PODCAST

Critical Care

ReachMD

science & medicine medicine

All Episodes

00:00:00

Breathing Beyond Birth: The Symptoms and Treatment of...

Critical Care ·

2023/11/15

Host: Jennifer Shu, MD, FAAPGuest: Steven H. Abman, MD Bronchopulmonary dysplasia is a chronic lung disease that can have significant impacts on a newborn’s overall respiratory health, making it imperative to know how to recognize and treat it. Tune in to hear Dr. Jennifer Shu talk about the symptoms, impacts, and treatment of bronchopulmonary dysplasia with Dr. Steven Abman, a Professor in the Department of Pediatrics at the University of Colorado School of Medicine and the

00:00:00

A Case for 4F-PCC: Mortality & Safety Data vs. Plasma

Critical Care ·

2023/07/28

Host: Jennifer Caudle, DO Guest: Michelle Kincaid, MD The largest study to date on 4F-PCC was conducted as an FDA postmarketing requirement in partnership between Kaiser Permanente and CSL Behring. The purpose of this long-term study was to compare the 45-day risk of thromboembolic events and all-cause mortality in adults with warfarin-associated major bleeding after treatment with KCENTRA®, Prothrombin Complex Concentrate (Human), or plasma. Take a deep dive into the data with Dr

00:00:00

Comparing In-hospital Mortality With Andexanet Alfa...

Critical Care ·

2023/03/31

Host: Gregory J. Fermann, MD Patients presenting to the hospital with severe bleeding and underlying treatment with Factor Xa (FXa) or Factor IIa inhibitors represent an enormous challenge to providers and clinicians since the approvals of apixaban, edoxaban, rivaroxaban, and dabigatran within the United States. Intracranial bleeding, intra-abdominal or thoracic trauma, gastrointestinal bleeding, and bleeding from any non-compressible source represent true life-threatening emergencies

00:00:00

Hematoma Expansion and Clinical Outcomes Comparison...

Critical Care ·

2023/03/31

Host: Natalie Kreitzer, MD, MS Patients presenting to the hospital with severe bleeding and underlying treatment with Factor Xa (FXa) or Factor IIa inhibitors represent an enormous challenge to providers and clinicians since the approvals of apixaban, edoxaban, rivaroxaban, and dabigatran within the United States. Intracranial bleeding, intra-abdominal or thoracic trauma, gastrointestinal bleeding, and bleeding from any non-compressible source represent true life-threatening

00:00:00

GI Bleeding and DOACs: Consensus Panel Findings

Critical Care ·

2023/03/31

00:00:00

ANNEXa-I: Recent Advances in the Treatment of...

Critical Care ·

2023/03/31

00:00:00

Pharmacy Perspectives: Real-World Management of...

Critical Care ·

2023/03/31

Host: Paul P. Dobesh, PharmD, FACC, FAHA, FCCP, BCPS, BCCP Patients presenting to the hospital with severe bleeding and underlying treatment with Factor Xa (FXa) or Factor IIa inhibitors represent an enormous challenge to providers and clinicians since the approvals of apixaban, edoxaban, rivaroxaban, and dabigatran within the United States. Intracranial bleeding, intra-abdominal or thoracic trauma, gastrointestinal bleeding, and bleeding from any non-compressible source represent true

00:00:00

Life-Threatening Bleeding in the Anticoagulated...

Critical Care ·

2023/03/31

00:00:00

Summary of Real-World Data for Treatment of Oral...

Critical Care ·

2023/03/31

00:00:00

Emergency Medicine Perspectives: Targeted vs....

Critical Care ·

2023/03/31

00:00:00

Andexanet Alfa Is Associated With Lower In-Hospital...

Critical Care ·

2023/03/31

00:00:00

Clinical Implications of ANNEXa-I on the Management...

Critical Care ·

2023/03/31

Host: W. Brian Gibler, MD, FACEP, FACC, FAHA Host: Gregory J. Fermann, MD Host: Natalie Kreitzer, MD, MS Host: Paul P. Dobesh, PharmD, FACC, FAHA, FCCP, BCPS, BCCP Patients presenting to the hospital with severe bleeding and underlying treatment with Factor Xa (FXa) or Factor IIa inhibitors represent an enormous challenge to providers and clinicians since the approvals of apixaban, edoxaban, rivaroxaban, and dabigatran within the United States. Intracranial bleeding,

00:00:00

Understanding the Role of TSLP in Severe Asthma

Critical Care ·

2023/03/13

Host: Matt Birnholz, MD Guest: Jonathan Corren, MD As recent research demonstrates the important role that TSLP plays in asthma inflammation, Dr Matt Birnholz is joined by Dr Jonathan Corren, an Associate Clinical Professor of Medicine and Pediatrics at David Geffen School of Medicine in Los Angeles. Together, they review how TSLP acts across the spectrum of asthma inflammation, the correlation of TSLP with clinical features of asthma, and more. ©2021 Amgen. All rights reserved

00:00:00

A Debate on Dosing Considerations: Perspectives on...

Critical Care ·

2022/11/09

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Fatima, Adhi, MD Guest: Mei Chang, PharmD Collaborative care is fundamental for critically ill patients, especially when it comes to medication dosing. To explore key considerations on dosing and share insights from their presentations at IDWeek 2022, Dr. Charles Turck is joined by Dr. Adhi Fatima from the Baylor College of Medicine and Mei Chang from the Montefiore Medical Center at the Weiler Division Einstein Campus.

00:00:00

Bridging Specialties™: Timely Diagnosis for ILD Patients

Critical Care ·

2022/05/13

Host: David Schulman, MD, MPH, FCCP Guest: Andrew H. Limper, MD Guest: Timothy A. Hernandez, MD There are many barriers to reaching a definitive diagnosis for idiopathic pulmonary fibrosis (IPF). To learn more about these obstacles—and how we can overcome them—Dr. David Schulman from the American College of Chest Physicians joins Dr. Tim Hernandez from the University of Texas Health Sciences Center and Dr. Andrew Limper from the Mayo Clinic to discuss the diagnosis of IPF. This

00:00:00

Investigating Inflammatory Mediators in Chronic...

Critical Care ·

2022/04/29

Host: Peter Howarth BSc, (Hons), MBBS, DM, FRCP Guest: Kathleen M. Buchheit, MD Guest: Philippe Gevaert, MD, PhD Do cytokines play a role in chronic rhinosinusitis? Dr. Peter Howarth is joined by Dr. Katie Buchheit, an Associate Professor of Medicine at Harvard Medical School, and Professor Philippe Gevaert, an ENT specialist at the Department of Otorhinolaryngology at Ghent University and the Upper Airway Research Laboratory, to explore the role of inflammatory mediators in

00:00:00

Investigating T2 Inflammation in Severe Asthma & COPD

Critical Care ·

2022/03/31

Host: Peter Howarth BSc, (Hons), MBBS, DM, FRCP Guest: Ian Pavord, MA, DM, FRCP, FERS, FMedSci Guest: Geoffrey Chupp, MD Type 2 inflammation can be challenging to identify. What should we be looking for in our patients with severe asthma and COPD? Joining Dr. Peter Howarth to discuss identifying this type of inflammation are Dr. Geoffrey Chupp from the Yale School of Medicine and Dr. Ian Pavord from the University of Oxford. This is a nonpromotional, non-CME disease state

00:00:00

Alleviating the Burden of Bleeding Disorders on...

Critical Care ·

2022/03/16

Host: Jennifer Caudle, DO Guest: Leonard A Valentino, MD Unfortunately, recognizing and diagnosing patients with bleeding disorders is only the first of many challenges. Once a diagnosis is reached, patients may face a variety of chronic health challenges and even altered family dynamics. Fortunately, recent treatments and developments—and even those on the horizon—can help alleviate the burden of bleeding disorders on patients and their loved ones. Join Dr. Jennifer Caudle as she

00:00:00

Exploring Xenotransplantation: Is the Future of Heart...

Critical Care ·

2022/03/14

Host: Matthew Sorrentino, MD Guest: Javed Butler, MD, MBA, MPH In a groundbreaking procedure, a 57-year-old man with life-threatening heart disease received a heart from a genetically altered pig. Surgeons at the University of Maryland Medical Center performed the 8-hour operation, making it the first successful transplant of a pig's heart into a human being. And while much is still uncertain, what could this achievement mean for the future of organ transplantation? That’s what

00:00:00

Optimizing Delivery with LAMAs: A Look at Key...

Critical Care ·

2022/02/24

Host: Muhammad Adrish MD, MBA, FCCP, FCCM Guest: Navitha Ramesh, MD, FCCP Inhalers are one of the most common methods of delivery for the treatment of COPD, but is it the best option for all of our patients? Associate Professor of Pulmonary Critical Care at Baylor College of Medicine, Dr. Muhammad Adrish, reviews LAMA use for COPD patients with Dr. Navitha Ramesh, Assistant Professor at Drexel University College of Medicine. This episode is produced in partnership with the American

107 results

Critical Care

All Episodes

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事